ArticleSAGE open medicine2026
A clinical epidemiological study of musculoskeletal injury occurrence and orthopedic management patterns among individuals with hypermobility spectrum disorders.
Article in SAGE open medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To determine the frequency and clinical associations of hypermobility spectrum disorders in a central orthopedic hospital. Methods: A clinical epidemiological, prospective hospital-based cross-sectional design was employed. Kuwait Ministry of Health Ethics Board approved the study (ref. no. 2022/2233). The Beighton score and the 2017 hypermobility spectrum disorders classification framework were used for screening over a 7-month period. Results: A total of 270 patients were examined, revealing a hypermobility spectrum disorder frequency of 21.1%; 31.7% in women and 4.7% in men. The mean age ± standard deviation was 39.4 ± 16.9 years, and 91.2% of identified cases were women. Among individuals with hypermobility spectrum disorders, 63.2% were classified as generalized hypermobility spectrum disorders, 26.3% as localized hypermobility spectrum disorders, and 10.5% as peripheral hypermobility spectrum disorders. The most frequent primary diagnosis or injury involved the knee (45.3%), hand (19.4%), and foot and ankle (19.4%). The most frequent secondary diagnosis or injury involved the knee (40.6%) and foot and ankle (28.1%). The most frequent tertiary diagnosis or injury involved the knee (50.0%) and the spine (20.0%). Management was most commonly directed toward the knee (45.7%), followed by the foot and ankle (12.7%). Statistically significant associations were identified between the Beighton score and primary diagnosis or injury ( Conclusion: Hypermobility spectrum disorder was frequently observed in a central orthopedic hospital and showed significant associations with orthopedic diagnoses and management pathways, indicating a substantial clinical burden and implications for orthopedic service planning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.